WHO ICTRP trial
Utility of neuECG to predict the occurrence and recurrence of atrial…
ChiCTR2000037245 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000037245 |
|---|---|
| Public title | Utility of neuECG to predict the occurrence and recurrence of atrial fibrillation after catheter ablation |
| Scientific title | Utility of neuECG to predict the occurrence and recurrence of atrial fibrillation after catheter ablation |
| Primary sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | China |
| Conditions | atrial fibrillation |
| Interventions | autonomic dependent and independent atrial fibrillation:Nil |
| Registration date | Aug 27, 2020 |
| Target size | autonomic dependent and independent atrial fibrillation:200 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: